BBR Partners’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

BBR Partners’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,000	Closed	-$53.2K	–	272
2024 Q1	$53.2K	Hold	20,000	–	–	﹤0.01%	252
2023 Q4	$47.4K	Buy	+20,000	New	+$35.4K	﹤0.01%	189

BBR Partners's KNTE Position: Q2 2024 in Review

BBR Partners sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 20,000 shares — an estimated $53.2K sold.

BBR Partners first reported a position in KNTE in Q4 2023 and held it in 2 quarters. The position peaked at $53.2K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

BBR Partners reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
BBR Partners sold 20,000 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $53.2K.
BBR Partners first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2023 and held it in 2 quarters.
BBR Partners's Kinnate Biopharma Inc. Common Stock position peaked at $53.2K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on BBR Partners's 13F filing for Q2 2024, filed 5 Aug 2024.